The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program
19 May 2025 (15:24 - 17:00)
Organised by: 
About the speaker
Medical University of Lodz, Lodz (Poland)
4 More presentations in this session
Doctor I. Beldhuis (Groningen, NL)
Doctor G. O Dea (Limerick, IE)
Doctor I. Meray (Tyre, LB)
Miss R. Vago (Debrecen, HU)
Access the full session
The Event
Heart Failure 2025
19 May 2025
15:24 CET
You may be interested in
Congress Session
